GB1067463A - Preventive treatment for infectious viral equine respiratory disease - Google Patents

Preventive treatment for infectious viral equine respiratory disease

Info

Publication number
GB1067463A
GB1067463A GB27955/64A GB2795564A GB1067463A GB 1067463 A GB1067463 A GB 1067463A GB 27955/64 A GB27955/64 A GB 27955/64A GB 2795564 A GB2795564 A GB 2795564A GB 1067463 A GB1067463 A GB 1067463A
Authority
GB
United Kingdom
Prior art keywords
respiratory disease
preventive treatment
infectious viral
equine respiratory
viral equine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB27955/64A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB1067463A publication Critical patent/GB1067463A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Equine influenza is prevented by inoculating the animal with a human influenza virus vaccine. The vaccine may be composed of human influenza viruses of types A e.g. PR-8, type A prime e.g. AA/1/77, type B e.g. Great Lakes, and Asian.
GB27955/64A 1963-07-08 1964-07-07 Preventive treatment for infectious viral equine respiratory disease Expired GB1067463A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29328663A 1963-07-08 1963-07-08

Publications (1)

Publication Number Publication Date
GB1067463A true GB1067463A (en) 1967-05-03

Family

ID=23128474

Family Applications (1)

Application Number Title Priority Date Filing Date
GB27955/64A Expired GB1067463A (en) 1963-07-08 1964-07-07 Preventive treatment for infectious viral equine respiratory disease

Country Status (1)

Country Link
GB (1) GB1067463A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0105364A1 (en) * 1982-04-16 1984-04-18 Cornell Res Foundation Inc Temperature sensitive reassortant viruses and a vaccine against equine influenza.
EP0113665A2 (en) * 1983-01-08 1984-07-18 The Wellcome Foundation Limited Novel viruses and vaccines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
CN108203716A (en) * 2016-12-20 2018-06-26 深圳市雅臣爱己生物工程有限公司 Anti- Pseudorabies virus pig source monoclonal antibody preparation method and its application
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0105364A1 (en) * 1982-04-16 1984-04-18 Cornell Res Foundation Inc Temperature sensitive reassortant viruses and a vaccine against equine influenza.
EP0105364A4 (en) * 1982-04-16 1986-09-15 Cornell Res Foundation Inc Temperature sensitive reassortant viruses and a vaccine against equine influenza.
EP0113665A2 (en) * 1983-01-08 1984-07-18 The Wellcome Foundation Limited Novel viruses and vaccines
EP0113665A3 (en) * 1983-01-08 1986-12-30 The Wellcome Foundation Limited Novel viruses and vaccines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US9345758B2 (en) 2005-04-21 2016-05-24 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US9913892B2 (en) 2005-04-21 2018-03-13 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US10258686B2 (en) 2005-04-21 2019-04-16 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11160859B2 (en) 2005-04-21 2021-11-02 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
CN108203716A (en) * 2016-12-20 2018-06-26 深圳市雅臣爱己生物工程有限公司 Anti- Pseudorabies virus pig source monoclonal antibody preparation method and its application

Similar Documents

Publication Publication Date Title
HUT69803A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
GB1183506A (en) New vaccines for combating influenza and the preparation thereof
SE7512828L (en) CALICIVIRUSVACCIN
GB1067463A (en) Preventive treatment for infectious viral equine respiratory disease
ES227680A2 (en) Heat and ultra-violet light attenuation of polio virus
IT976125B (en) PROCEDURE AND DEVICE FOR THE EXTRACTION OF BLOOD FROM THE BODY OF KILLED ANIMALS
ES2058100T3 (en) COMBINED VACCINE.
GB1099555A (en) Process for the manufacture of influenza vaccines
IT1023004B (en) METHOD FOR PREPARING VACCINES FOR VETERINARY USE FOR FEILINI'S IMPECTIVE ENTERITIS RINOTRACHEITE MAMMALITET POVINA HERPES I VIRUS POVINE MAMMALITIS HERPES CAT LEUKEMIA VIRUSES AND FELINE PICORMAVIRUSES
GB1462545A (en) Feline rhinotracheitis vaccine and production thereof
Hosai et al. Studies on live attenuated mumps virus vaccine. 1. Attenuation of mumps virus by serial passage in the chorioallantoic cavity of developing chick embryos and field trials by the inhalation method
Pogodina An experimental study on the pathogenesis of tick-borne encephalitis following alimentary infection. Part 2. A study of the methods of excretion of viruses from the body of the white mouse
AU3716468A (en) Preventive treatment for infectious viral equine respiratory disease, equine encephalomyelitis and equine tetanus and vaccine therefor
AU285604B2 (en) Preventive treatment for infectious viral equine respiratory disease
GB1212886A (en) Equine vaccine and vaccination treatment
AU4658364A (en) Preventive treatment for infectious viral equine respiratory disease
Mordhorst Quantitation of the infectivity for cynomolgus monkeys of egg-grown inclusion conjunctivitis virus. A comparison of the clinical course of the experimental disease, the appearance of inclusion bodies and the regular recovery of the viral agent
FR2143588A1 (en) Goose hepatitis live vaccine - for active immunization of water fowl
RU92006181A (en) ATTENUATED COLD-ADAPTED STRAIN OF INFLUENZA VIRUS В / USSR / 60/69 FOR OBTAINING LIVING INTRANASAL INFLUENZA Vaccine
CH416950A (en) Device for cooling and heating the blood, especially during surgical operations
CA874949A (en) Preventive treatment for infectious viral equine respiratory disease
GB949400A (en) Poliomyelitis vaccines
FR2010678A1 (en) Stable polyvalent vaccine for treatment of dogs - active against Carre's disease, hepatitis and leptospirosis
CA652677A (en) Vaccine preparation from attenuated infectious canine hepatitis virus
CA636550A (en) Trivalent poliomyelitis live virus vaccine